Scientists in China developed the vaccine at the National Center for Diagnostic Reagents and Vaccine Engineering Technology of Xiamen University. Before SFDA approved the vaccine, the third phase clinical trial was published in the medical journal The Lancet. Experiments show that the effective rate of vaccine in preventing infection is 100%.

Chinese Pinyin: Miao Yi (Dachang cherishes Jun) who worships the five elements of the ancestors.

Composition and characteristics

This product is made by mixing the structural protein of hepatitis E virus expressed by genetically engineered Escherichia coli with aluminum adjuvant after purification and renaturation. This product is a white suspension, which can be precipitated and easily shaken.

Accessories: sodium chloride, disodium hydrogen phosphate, potassium dihydrogen phosphate, potassium chloride, aluminum hydroxide, thiomersal and water for injection.

Inoculation target

This product is suitable for 16 years old and above susceptible population. Recommended for key high-risk groups of hepatitis E virus infection, such as livestock breeders, catering practitioners, students or military officers and soldiers, women of childbearing age, travelers in epidemic areas, etc.

Function and use

After inoculation, this product can stimulate the body to produce immunity against hepatitis E virus and can be used to prevent hepatitis E.

standard

0.5ml each. Every time 1 time, the dosage for human use is 0.5ml, containing 30μg of purified recombinant hepatitis E virus antigen.